{"lastModified":"2026-04-20T22:00:22","links":[{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacja.xsp?typ=int&nr=16270","rel":"web-description"},{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacjaTresc.xsp?key=DSRCAP","rel":"web-body"},{"href":"https://api.sejm.gov.pl/sejm/term10/interpellations/16270/body","rel":"body"}],"num":16270,"receiptDate":"2026-03-30","term":10,"title":"Interpelacja w sprawie zastosowania nowego leku sterydowego na rzadką chorobę dystrofię mięśniową Duchenne'a","answerDelayedDays":0,"from":["027","040","092","242"],"recipientDetails":[{"answerDelayedDays":0,"name":"minister zdrowia","sent":"2026-04-01"}],"replies":[{"attachments":[{"URL":"https://api.sejm.gov.pl/sejm/term10/interpellations/attachment/ATTDTBHUD/i16270-o1.pdf","lastModified":"2026-04-20T22:00:22","name":"i16270-o1.pdf"}],"from":"Podsekretarz stanu Katarzyna Anna Kacperczyk","key":"DTBHUD","lastModified":"2026-04-20T22:00:22","links":[{"href":"https://sejm.gov.pl/sejm10.nsf/interpelacjaTresc.xsp?key=DTBHUD","rel":"web-body"},{"href":"https://api.sejm.gov.pl/sejm/term10/interpellations/16270/reply/DTBHUD/body","rel":"body"}],"onlyAttachment":true,"prolongation":false,"receiptDate":"2026-04-17"}],"sentDate":"2026-04-01","to":["minister zdrowia"]}